NCT05229497 2026-03-09
A Phase Ib/II Study of AK112 in Combination With AK117 in Advanced Malignant Tumors
Akeso
Phase 1/2 Active not recruiting
Clinical Trials
11 trialsNCT05214482 2026-03-03
A Study of AK112 in Advanced Malignant Tumors
Akeso
Phase 1/2 Completed
NCT05223231 2026-02-02
Evaluation of LBL-019 Monotherapy or Combined With Anti-PD-1 Antibody in the Treatment of Advanced Malignant Tumors
Nanjing Leads Biolabs Co.,Ltd
Phase 1/2 Completed
NCT06877650 2026-01-29
First-in-Human Investigation of JMT108 Injection in Participants With Advanced Malignant Tumors
Shanghai JMT-Bio Inc.
Phase 1/2 Recruiting
NCT05102006 2025-06-03
A Phase Ib/II Clinical Study of LBL-007 in Combination With Toripalimab in Treatment of Advanced Malignant Tumors
Nanjing Leads Biolabs Co.,Ltd
Phase 1/2 Completed
NCT05991583 2025-01-17
A Clinical Trial to Evaluate Effect of IBB0979 in Patients With Advanced Malignant Tumors
SUNHO（China）BioPharmaceutical CO., Ltd.
Phase 1/2 Recruiting
NCT06770881 2025-01-13
JSKN033 in Chinese Subjects with Advanced Malignant Tumors
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Phase 1/2 Not yet recruiting
NCT06223841 2024-02-20
A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors
SUNHO（China）BioPharmaceutical CO., Ltd.
Phase 1/2 Recruiting
NCT05396391 2023-07-20
A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors
SUNHO（China）BioPharmaceutical CO., Ltd.
Phase 1/2 Unknown
NCT04980690 2023-03-10
Clinical Trial of IBC0966 in Patients With Advanced Malignant Tumors
SUNHO（China）BioPharmaceutical CO., Ltd.
Phase 1/2 Unknown
NCT05235542 2022-08-11
A Phase Ib/II Study of AK104 and AK117 in Combination With or Without Chemotherapy in Advanced Malignant Tumors
Akeso
Phase 1/2 Unknown